Takeda Pharmaceutical (TAK): Insider filed to sell ~$1.12M

~$1.12M

planned to sell · 56K shares, around Nov 1, 2026

Planned for

Nov 1, 2026

Notice filed

Oct 30, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

What came next

1. Nov 2, 2026InsiderOfficer sold ~$974K of TAK shares in the open market
2. Nov 4, 2026InsiderOfficer sold ~$1.16M of TAK shares in the open market

How to read SEC Form 144

Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.

Full guide: What is an SEC Form 144?

What else is on file for Takeda Pharmaceutical

For Takeda Pharmaceutical, OQRO holds 4 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TAK page.

How this filing works

• SEC Form 144
• Rule 10b5-1 trading plans

Other disclosures at Takeda Pharmaceutical

• SEC Form 4Nov 5, 2026
• SEC Form 4Nov 4, 2026
• SEC Form 144Oct 30, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRFeb 11, 2026

Everything OQRO holds on this company is on its TAK page.